• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌节基因突变对肥厚型心肌病患者左心房功能的影响。

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.

机构信息

Department of Internal Medicine, Division of Cardiology, Kyung Hee University School of Medicine, Seoul, South Korea.

Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-Ro, Gangnam-Gu, Seoul, 06273, Republic of Korea.

出版信息

Cardiovasc Ultrasound. 2021 Jan 6;19(1):4. doi: 10.1186/s12947-020-00233-y.

DOI:10.1186/s12947-020-00233-y
PMID:33407484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789152/
Abstract

BACKGROUND

Left atrial (LA) enlargement and dysfunction are related to clinical course in patients with hypertrophic cardiomyopathy (HCM). We aimed to investigate genetic contribution to LA structural and functional remodeling.

METHODS

Two hundred twelve patients were consecutively enrolled, and echocardiography and extensive genetic analysis were performed. Cardiac magnetic resonance (CMR) was performed in 135 patients. Echocardiography was also performed in controls (n = 30).

RESULTS

Patients with HCM had lower late-diastolic mitral annular velocity (a') and higher LA volume index (LAVI) than controls. Patients with pathogenic or likely pathogenic sarcomere gene mutations (PSM, n = 67, 32%) had higher LAVI and lower CMR-derived LA total emptying fraction (37.0 ± 18.5 vs. 44.2 ± 12.4%, p = 0.025). In patients without AF (n = 187), the PSM had lower a' (6.9 ± 2.0 vs. 7.8 ± 1.9 cm/s, p = 0.004) than others. The PSM had higher prevalence and amount of late gadolinium enhancement (LGE) in the left ventricle (LV). In multivariate analysis, PSM was significantly related to lower a' independent of E/e', LV mass index, and LAVI. However, the relation significantly attenuated after adjustment for the extent of LGE in the LV, suggesting common myopathy in the LV and LA. In addition, PSM was significantly related to lower LA total emptying fraction independent of age, E/e', s', LV ejection fraction, LV myocardial global longitudinal strain and %LGE mass.

CONCLUSIONS

PSM was related to LA dysfunction independent of LV filling pressure and LAVI, suggesting its contribution to atrial myopathy in HCM.

摘要

背景

左心房(LA)扩大和功能障碍与肥厚型心肌病(HCM)患者的临床病程有关。我们旨在研究遗传因素对 LA 结构和功能重塑的贡献。

方法

连续招募了 212 名患者,并进行了超声心动图和广泛的基因分析。135 名患者进行了心脏磁共振(CMR)检查。对照组(n=30)也进行了超声心动图检查。

结果

与对照组相比,HCM 患者的舒张晚期二尖瓣环速度(a')较低,左心房容积指数(LAVI)较高。有致病性或可能致病性肌节基因突变(PSM,n=67,32%)的患者 LAVI 较高,CMR 测定的左心房总排空分数较低(37.0±18.5%比 44.2±12.4%,p=0.025)。在没有房颤(AF)的患者(n=187)中,PSM 的 a'(6.9±2.0 比 7.8±1.9 cm/s,p=0.004)较低。PSM 患者的左心室(LV)有更高的晚期钆增强(LGE)发生率和程度。在多变量分析中,PSM 与较低的 a'独立于 E/e'、LV 质量指数和 LAVI 相关。然而,在调整 LV 中 LGE 的程度后,这种关系显著减弱,提示 LV 和 LA 中有共同的肌病。此外,PSM 与较低的 LA 总排空分数独立于年龄、E/e'、s'、LV 射血分数、LV 心肌整体纵向应变和%LGE 质量相关。

结论

PSM 与 LA 功能障碍有关,与 LV 充盈压和 LAVI 无关,提示其对 HCM 中的心房肌病有贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/ecdf91cd33f2/12947_2020_233_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/de2ee11e873f/12947_2020_233_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/34563c489513/12947_2020_233_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/ecdf91cd33f2/12947_2020_233_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/de2ee11e873f/12947_2020_233_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/34563c489513/12947_2020_233_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/166b/7789152/ecdf91cd33f2/12947_2020_233_Fig3_HTML.jpg

相似文献

1
Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.肌节基因突变对肥厚型心肌病患者左心房功能的影响。
Cardiovasc Ultrasound. 2021 Jan 6;19(1):4. doi: 10.1186/s12947-020-00233-y.
2
Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.肥厚型心肌病肌节突变携带者左心房结构和功能与左心室肥厚的关系。
J Cardiovasc Magn Reson. 2017 Dec 28;19(1):107. doi: 10.1186/s12968-017-0420-0.
3
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.肥厚型心肌病合并心房颤动患者的心脏磁共振成像结果
J Cardiovasc Magn Reson. 2009 Sep 9;11(1):34. doi: 10.1186/1532-429X-11-34.
4
Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.肥厚型心肌病患者右心室插入点延迟钆增强的范围:与舒张功能障碍的关系
Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18.
5
Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.斑点追踪超声心动图测量肥厚型心肌病患者左心房主动功能的增量价值
Echocardiography. 2018 Aug;35(8):1138-1148. doi: 10.1111/echo.13886. Epub 2018 Apr 12.
6
Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.在肥厚型心肌病中,左心房纤维化与左心室心肌延迟强化程度及左心室应变相关。
Int J Cardiovasc Imaging. 2019 Jul;35(7):1309-1318. doi: 10.1007/s10554-019-01551-7. Epub 2019 Feb 21.
7
[The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].肥厚型心肌病患者中心脏磁共振特征追踪应变与心肌延迟钆增强之间的关联
Kardiologiia. 2023 Feb 28;63(2):52-58. doi: 10.18087/cardio.2023.2.n2380.
8
Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.肥厚型心肌病的左心房机械功能与整体应变
PLoS One. 2016 Jun 23;11(6):e0157433. doi: 10.1371/journal.pone.0157433. eCollection 2016.
9
Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.左心房心肌病变与肥厚型心肌病肌节突变的相关性:磁共振特征追踪技术评估左心房应变的新视角。
Eur Radiol. 2024 Feb;34(2):1026-1036. doi: 10.1007/s00330-023-10128-x. Epub 2023 Aug 28.
10
An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.二维斑点追踪超声心动图对肥厚型梗阻性心肌病患者室间隔消融术前及术后1年左心房功能的评估。
Echocardiography. 2017 Mar;34(3):407-414. doi: 10.1111/echo.13460. Epub 2017 Jan 28.

引用本文的文献

1
Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review.肥厚型心肌病的超极化磁共振成像:一篇叙述性综述。
Clin Med Insights Cardiol. 2025 Aug 29;19:11795468251369234. doi: 10.1177/11795468251369234. eCollection 2025.
2
Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases.肌钙蛋白I——对其功能、结构、进化及在肌肉疾病中的作用的全面综述。
Anim Cells Syst (Seoul). 2025 Jul 28;29(1):446-468. doi: 10.1080/19768354.2025.2533821. eCollection 2025.
3
Left atrial volume quantification by transthoracic echocardiography versus cardiovascular magnetic resonance: a systematic review and meta-analysis.

本文引用的文献

1
Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.肌节和线粒体相关多基因变异对肥厚型心肌病表型的差异贡献。
Mitochondrion. 2020 Jul;53:48-56. doi: 10.1016/j.mito.2020.04.010. Epub 2020 May 4.
2
Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients.高血压患者左心房功能障碍的早期检测:CMR 特征追踪技术评估。
Eur Radiol. 2020 Feb;30(2):702-711. doi: 10.1007/s00330-019-06397-0. Epub 2019 Sep 12.
3
Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.
经胸超声心动图与心血管磁共振对左心房容积的定量评估:一项系统评价和荟萃分析。
Int J Cardiovasc Imaging. 2025 Jul 23. doi: 10.1007/s10554-025-03455-1.
4
Genetic insights into hypertrophic cardiomyopathy: pathogenesis, diagnosis, and therapeutic implications.肥厚型心肌病的遗传学见解:发病机制、诊断及治疗意义
J Cardiovasc Imaging. 2025 Jul 21;33(1):9. doi: 10.1186/s44348-025-00055-4.
5
Determinants and effects of microvascular obstruction on serial change in left ventricular diastolic function after reperfused acute myocardial infarction.微血管阻塞对再灌注急性心肌梗死后左心室舒张功能连续变化的影响及决定因素
Front Cardiovasc Med. 2024 Apr 26;11:1338940. doi: 10.3389/fcvm.2024.1338940. eCollection 2024.
6
Fine tuning contractility: atrial sarcomere function in health and disease.精细调节收缩性:健康与疾病状态下的心房肌节功能
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H568-H583. doi: 10.1152/ajpheart.00252.2023. Epub 2023 Dec 29.
7
Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation.肥厚型心肌病合并心房颤动患者的多模态成像
Diagnostics (Basel). 2023 Sep 25;13(19):3049. doi: 10.3390/diagnostics13193049.
8
Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers.肥厚型心肌病:遗传基础、结局、相互关系及其修饰因素。
Medicina (Kaunas). 2023 Aug 4;59(8):1424. doi: 10.3390/medicina59081424.
9
Evaluation of the relationship between left atrial strain and exercise tolerance in patients with hypertrophic cardiomyopathy by treadmill stress echocardiography.通过平板运动负荷超声心动图评估肥厚型心肌病患者左心房应变与运动耐量之间的关系。
Front Cardiovasc Med. 2023 May 15;10:1168514. doi: 10.3389/fcvm.2023.1168514. eCollection 2023.
10
Emerging Indicators of Left Atrial Function Evaluation Considering the Unique Characteristics of Hypertrophic Cardiomyopathy.考虑肥厚型心肌病独特特征的左心房功能评估新指标
J Cardiovasc Imaging. 2023 Jan;31(1):49-50. doi: 10.4250/jcvi.2022.0116.
左房应变率低值与肥厚型心肌病患者不良结局相关。
J Am Soc Echocardiogr. 2019 May;32(5):593-603.e1. doi: 10.1016/j.echo.2019.01.007. Epub 2019 Mar 20.
4
Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.心脏磁共振成像显示,肥厚型心肌病伴阵发性心房颤动患者左心房纤维化负担重。
JACC Clin Electrophysiol. 2019 Mar;5(3):364-375. doi: 10.1016/j.jacep.2018.10.016. Epub 2018 Dec 26.
5
Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.心血管磁共振特征追踪评估肥厚型心肌病左心房功能的预后价值
Int J Cardiovasc Imaging. 2019 Jun;35(6):1055-1065. doi: 10.1007/s10554-019-01534-8. Epub 2019 Jan 31.
6
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).肥厚型心肌病的基因型与疾病终生负担:来自肌节性人类心肌病注册研究(SHaRe)的见解。
Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.
7
Left Atrium as an Active Component of the Pathophysiology in HCM.左心房作为肥厚型心肌病病理生理学的一个活跃组成部分。
Int Heart J. 2018;59(5):906-908. doi: 10.1536/ihj.18-441.
8
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.CRISPR/Cas9 编辑人多能干细胞诱导的心肌细胞模型揭示心律失常、收缩力减弱和能量耗竭可能成为肥厚型心肌病的治疗靶点。
Eur Heart J. 2018 Nov 14;39(43):3879-3892. doi: 10.1093/eurheartj/ehy249.
9
Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.基于心电图的肥厚型心肌病肥厚模式和纤维化程度预测:与心脏磁共振成像的对比研究。
Int J Cardiovasc Imaging. 2018 Oct;34(10):1619-1628. doi: 10.1007/s10554-018-1365-6. Epub 2018 May 4.
10
CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation.CardioClassifier:针对临床基因组解读的疾病和基因特异性计算决策支持。
Genet Med. 2018 Oct;20(10):1246-1254. doi: 10.1038/gim.2017.258. Epub 2018 Jan 25.